Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2020

May 21, 2020

BUY
$5.05 - $8.85 $24,240 - $42,480
4,800 Added 31.58%
20,000 $2,000
Q4 2019

Feb 14, 2020

BUY
$8.03 - $11.7 $89,936 - $131,039
11,200 Added 280.0%
15,200 $13,000
Q3 2019

Nov 12, 2019

BUY
$9.05 - $12.22 $18,100 - $24,440
2,000 Added 100.0%
4,000 $3,000
Q3 2018

Nov 09, 2018

BUY
$13.05 - $19.05 $26,100 - $38,100
2,000 New
2,000 $13,000

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $387M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.